key: cord-0024992-wo8blvsp
authors: Xie, Li-Min; Yin, Xin; Xie, Tian-Ao; Su, Jian-Wen; Huang, Qin; Zhang, Jing-Hao; Huang, Yin-Fei; Guo, Xu-Guang
title: Meta-Analysis of the Diagnostic Efficacy of the Luminex xTAG Respiratory Viral Panel FAST v2 Assay for Respiratory Viral Infections
date: 2021-12-09
journal: Yonsei Med J
DOI: 10.3349/ymj.2022.63.1.95
sha: fe7b2bc47055d0bd131b54302bf64d01bc33a4fe
doc_id: 24992
cord_uid: wo8blvsp

PURPOSE: Acute respiratory viral infections pose significant morbidity and mortality, making it essential to diagnose respiratory viral infections rapidly. In this study, the diagnostic efficacy of the Luminex xTAG Respiratory Virus Panel (RVP) FAST v2 test was evaluated on respiratory viral infections. MATERIALS AND METHODS: Information was retrieved from electronic databases, including Embase, Web of Science, PubMed, and Cochrane Library, for systematic review. Studies that fulfilled predefined inclusion criteria were included. After the extraction of information, statistical software was utilized for quality evaluation, data analysis, and assessment of publication bias. RESULTS: Eighty groups in fourfold tables from nine articles were included to perform statistical analyses. Therein, the mean specificity and mean sensitivity of Luminex xTAG RVP FAST v2 test for the detection of respiratory viral infections were 0.99 (0.98–0.99) and 0.88 (0.87–0.90), respectively. Additionally, the negative and positive likelihood ratios were 0.14 (0.11–0.19) and 87.42 (61.88–123.50), respectively. Moreover, the diagnostic odds ratio and area under the curve of summary receiver operating characteristic were 714.80 and 0.9886, respectively. CONCLUSION: The Luminex xTAG RVP FAST v2 test could be a reliable and rapid diagnostic method for multiple respiratory viral infections.

can lead to death. A such, the mortality rate of respiratory viral infections is noteworthy. 14 At present, traditional means of rapid detection are generally used to detect respiratory viruses. Cell culture-based virus isolation is generally regarded as the "gold standard" for the detection and diagnosis of viruses. 15 Among rapid detection methods, nucleic acid amplification test and direct fluorescent antibody test have recently been developed as new tools for clinical diagnosis. 5, 7, [16] [17] [18] The Luminex xTAG Respiratory Viral Panel (RVP) FAST v2 assay (Luminex Molecular Diagnostics, Toronto, ON, Canada) is a qualitative multiplex molecular diagnostic assay for simultaneous detection of 19 viral types and subtypes within 2 hours in a single reaction, including IFVA, IFVB, AdV, PIV, RSV, HCoV, HMPV, HBoV, and HEV/HRV. 9, 15, 19, 20 The xTAG and xMAP ® Technology platforms offer a streamlined, quality, high-performance workflow for rapid screening and detection of multiple respiratory viruses. 16, 17 Research has shown that the Luminex xTAG RVP FAST v2 is more cost-effective than standard viral direct fluorescent antibody and culture 21 and that its positive rate of detection for major respiratory viruses (RSV, AdV, influenza viruses, and PIV) was higher than that of conventional viral isolation and direct immunofluorescence methods, making it of potential use for diagnosing respiratory viral infections. 19 This study aimed to assess the accuracy of xTAG RVP FAST v2 for the detection of respiratory viral infections via a systematic review of the literature.

We performed a comprehensive search of four databases (Embase, Web of Science, PubMed, and Cochrane Library) to identify eligible studies until August 14, 2021. In those databases, we searched for articles using the following strategy: ("xTAG RVP FAST v2" OR "xTAG RVP assay" OR "xTAG respiratory viral panel" OR "xTAG respiratory virus panel" OR "xTAG respiratory viral panel assay" OR "xTAG respiratory virus panel assay").

Before screening the publications, we adopted inclusion and exclusion criteria in advance. Inclusion criteria were as follows: 1) the purpose and contents of studies should be relevant to xTAG RVP FAST v2 and respiratory viral infections; 2) diagnosis-based studies; 3) original research; and 4) data could be fully extracted. Studies were excluded if they were 1) duplicates, letters, oral presentations, conference abstracts, under publication articles, or case reports; 2) lacking a reference standard; 3) not appropriate for extracting data; or 4) irrelevant studies.

Extracted data included the first author's full name, research design, year of publication, reference standard, type of samples, source of patients or samples, type of virus, true-negative, true-positive, false-negative, false-positive, and total number of samples.

The Quality Assessment of Diagnostic Accuracy Studies (QUA-DAS-2) tool, which is designed for systematic reviews of diagnostic studies, was utilized. QUADAS-2 covered four aspects: index test, reference standard, patient selection, and timing and flow. For this purpose, two researchers assessed the same article and then discussed it to achieve a consistent result. If a consensus could not be reached, a third researcher would intervene and participate in the decision-making process.

In total, three relevant statistical software packages were used to perform statistical analysis in our study. First, we performed statistical analysis of the extracted fourfold table data and then divided the fourfold table data into subgroups for further analysis according to the virus samples. We presented results on mean specificity, sensitivity, positive likelihood ratio (PLR), negative likelihood ratio (NLR), diagnostic odds ratio (DOR) in forest plots, and summary receiver operating characteristic (SROC) curves with Meta DiSc 1.4 software (Ramony Cajal Hospital, Madrid, Spain). Subgroup analysis was performed according to the type of virus. A bivariate boxplot was constructed to analyze outlier results. In addition, Stata 12.0 software (StataCorp LLC, College Station, TX, USA) was utilized to identify potential publication bias. All evaluations of methodological quality were performed using Review Manager 5.3 software (The Nordic Cochrane Centre, Copenhagen, Denmark).

Herein, 285 articles in total were collected, all of which were retrieved systematically from electronic databases. After excluding 142 duplicates, 143 articles remained. After reading the title/abstract and checking the article type, we screened 103 articles. After further reviewing the full-text, nine qualified studies were selected according to the exclusion and inclusion criteria. [22] [23] [24] [25] [26] [27] [28] [29] [30] The specific reasons for exclusion as listed in Supplementary Fig. 1 (only online). 31

Among the nine studies, both prospective and retrospective studies were included, and we extracted 80 four-grid tables from these studies. These studies reported the results of xTAG RVP FAST v2 for detecting multiple viruses (four-lattice tables are shown in Table 1 ). The patient samples in the included articles were from Canada, France, Finland, Italy, and Vietnam, respectively.

The forest plots analyzed by using Meta-DiSc statistical software are illustrated in Figs. 1 

Different respiratory viruses were grouped into subgroups. We combined data on the same viruses from different studies for further analysis: an individual study could have comprised more than one subgroup due to different subtypes of a virus. Subgroup analyses revealed differences in mean sensitivity and specificity between the subgroups ( 

Quality evaluation in each study was carried out independently by two researchers using the QUADAS-2 tool in Review Manager 5.3 software. Fig. 3B shows the assessment results of the risk of bias and applicability concerns in these articles. Finally, we concluded that eight of the studies posed little concern in regards to applicability and bias, except for Jokela's. 25 Bivariate boxplots revealed that several sets of data were out of the circles in Fig. 3C .

For a visualized inspection of publication bias, robustness of the meta-analysis to publication bias was assessed using Deek's funnel plot asymmetry test. The evaluation results indicated low publication bias (p>0.05) (Fig. 3D) . Deek's funnel plot asymmetry testing for individual viruses was also performed as shown in Table 2 .

Precise and rapid recording of respiratory specimens may have a significant influence on disease progression. 32 Accordingly, we evaluated the efficacy of xTAG RVP FAST v2 to detect respiratory viruses. Herein, the mean specificity and sensitivity of xTAG RVP FAST v2 were 0.99 and 0.88, respectively. The NLR, PLR, and DOR were 0.14, 87.42, and 714.80, respectively. Our results reflected high diagnostic value of xTAG RVP FAST v2 for the detection of respiratory viral infections. For subgroup analysis, we segregated the retrieved data into eight groups based on the type of virus [IFVA, PIV, hCoV, RSV, hMPV, AdV, IFVB and enteroviruses/rhinoviruses (EV/RV)]. Except for AdV and IFVB, the sensitivity of detecting other viruses was above 0.85. Radko, et al. 33 found the sensitivity of xTAG for IFVB to be the lowest at 0.75, compared with others over 0.9. However, more clinical data are required to show whether the xTAG RVP FAST v2 test is more sensitive to specific viruses. Meanwhile, we also employed bivariate boxplots to investigate outlier results. In one study, Esposito, et al. 28 found that xTAG RVP FAST v2 has low sensitivity to AdV: they had previously concluded that the Luminex NxTAG Respiratory Pathogen Panel was more suitable for detecting AdV. 34, 35 Another outlier outcome was from a study in the detection of RV, 29 although this article included only 42 samples, which were too few for accurate analysis of sensitivity.

Research has shown that traditional detection methods are fraught with challenges and have several limitations: First, cultivation is time-consuming and laborious, and rapid detection of viral antigens is not highly sensitive to the majority of viruses. Second, although quantitative reverse transcription-PCR (RT-qPCR) has significantly improved the etiological diagnosis of respiratory infections at lower cost and less time required for analysis, 36 multiplex RT-qPCR is technically challenging and may lead to low sensitivity. 26 Therefore, multiple analyses involving amplification using suspension microarrays aiming to detect a series of respiratory viruses can provide practical solutions. 23, 28 The xTAG RVP assay is based on suspension microarray technology, which enables the detection of a large number of targets in a single reaction. 26 Moreover, xTAG RVP FAST v2 can rapidly detect 19 respiratory viruses and their subtypes simultaneously in only 5 hours, providing benefits to manpower, detection efficiency, and determination of infectious pathogens in the shortest amount of time. 19, 22 For comparison, BioFire ® (https://www.biofiredx.com/products/the-filmarray-panels/) has reported an overall sensitivity of 0.97 in their BioFire Respiratory 2.1 (RP2.1) Panel, targeting 22 respiratory viruses and bacteria. In respiratory viral analyses, RP2.1 showed a positive percent agreement of 97%. 37 The Esposito, et al. 28 Gadsby, et al. 22 Jokela, et al. 25 Luchsinger, et al. 29 Mansuy, et al. 26 Pabbaraju, et al. 23 Salez, et al. 27 Takao, et al. 24 Thi 38 Overall, there were several limitations in our study. We were unable to determine why different virus detection rates were different in xTAG RVP FAST v2, such as AdV and IFVB. Also, while two researchers evaluated article quality as a group, a third scholar was utilized in cases of disagreement; hence, we cannot ensure that there was no manual bias.

We assessed the efficacy of xTAG RVP FAST v2 for detecting respiratory viral infections. In summary, xTAG RVP FAST v2 appears to be a reliable and rapid diagnostic method for multiple respiratory viral infections. In clinical practice, xTAG RVP FAST v2 shows high diagnostic performance, especially for detecting IFVA, PIV, hCoV, hMPV, EV/RV, and RSV. *One study may have been included more than once due to different subtypes of a virus; † p value from Deek's funnel plot asymmetry test used to assess the publication bias.

Asymptomatic shedding of respiratory virus among an ambulatory population across seasons

Clinical significance of multiple respiratory virus detection

Viral-bacterial co-infections in the respiratory tract

Emerging, novel, and known influenza virus infections in humans

Evaluation of multiple test methods for the detection of the novel 2009 influenza A (H1N1) during the New York City outbreak

Comparison of a singleplex real-time RT-PCR assay and multiplex respiratory viral panel assay for detection of influenza "A" in respiratory specimens

Comparison of a multiplex realtime PCR assay with a multiplex Luminex assay for influenza virus detection

Broad reactivity of the Luminex xTAG respiratory virus panel (RVP) assay for the detection of human rhinoviruses

xTAG RVP assay: analytical and clinical performance

Strengths and weaknesses of FDA-approved/ cleared diagnostic devices for the molecular detection of respiratory pathogens

Respiratory viruses among children with non-severe communityacquired pneumonia: a prospective cohort study

Surveillance for emerging respiratory viruses

Single and multiple respiratory virus infections and severity of respiratory disease: a systematic review

Acute respiratory distress syndrome after surgery: can the risk be decreased?

Development of a respiratory virus panel test for detection of twenty human respiratory viruses by use of multiplex PCR and a fluid microbead-based assay

A large-scale study of respiratory virus infection over 2 years using the Luminex xTAGRVP assay

Comparison of the Luminex xTAG respiratory viral panel fast v2 assay with Anyplex II RV16 detection kit and AdvanSure RV real-time RT-PCR assay for the detection of respiratory viruses

Nucleic acid amplification tests for detection of respiratory viruses

Detection of respiratory viruses from ARTI patients by xTAG RVP fast v2 assay and conventional methods

Comparison of the conventional multiplex RT-PCR, real time RT-PCR and Luminex xTAG ® RVP fast assay for the detection of respiratory viruses

Semi-quantitative analysis of influenza samples using the Luminex xTAG ® respiratory viral panel kit

Comparison of the Luminex respiratory virus panel fast assay with in-house real-time PCR for respiratory viral infection diagnosis

Comparison of the Luminex xTAG respiratory viral panel with xTAG respiratory viral panel fast for diagnosis of respiratory virus infections

Simultaneous multiple assay (Luminex xTAG respiratory viral panel FAST assay) efficacy in human respiratory virus detection

Performance of the Luminex xTAG respiratory viral panel fast in a clinical laboratory setting

Performance of a rapid molecular multiplex assay for the detection of influenza and picornaviruses

Evaluation of four commercial multiplex molecular tests for the diagnosis of acute respiratory infections

Partial comparison of the NxTAG respiratory pathogen panel assay with the Luminex xTAG respiratory panel fast assay V2 and singleplex real-time polymerase chain reaction for detection of respiratory pathogens

Comparison of Luminex xTAG ® RVP fast assay and real time RT-PCR for the detection of respiratory viruses in adults with community-acquired pneumonia

Evaluation of the Luminex xTAG respiratory viral panel FAST v2 assay for detection of multiple respiratory viral pathogens in nasal and throat swabs in Vietnam

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

Timely diagnosis of respiratory tract infections: evaluation of the performance of the Respifinder assay compared to the xTAG respiratory viral panel assay

Evaluation of three commercial multiplex assays for the detection of respiratory viral infections

Identification of human adenovirus in respiratory samples with Luminex respiratory virus panel fast V2 assay and real-time polymerase chain reaction

Characteristics and their clinical relevance of respiratory syncytial virus types and genotypes circulating in Northern Italy in five consecutive winter seasons

Lower respiratory viral illnesses: improved diagnosis by molecular methods and clinical impact

Multicenter evaluation of BioFire FilmArray respiratory panel 2 for detection of viruses and bacteria in nasopharyngeal swab samples

Comparison of the Biofire FilmArray RP, Genmark eSensor RVP, Luminex xTAG RVPv1, and Luminex xTAG RVP fast multiplex assays for detection of respiratory viruses